Pro PG receives S19A approval for Benzylpenicillin sodium 1200mg powder for injection

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.

For current Australian shortage and supply information, see medicine shortages in Australia.

Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered BENPEN benzylpenicillin (as sodium) 3g and 1.2g powder for injection vial, AUST R: 10326

ProPG has arranged for an alternative product Benzylpenicillin sodium 1200 mg powder for

injection (Genus Pharmaceuticals).